| Literature DB >> 34917102 |
Richard D Lally1, Kathleen Donaleshen2, Ulalo Chirwa2, Katie Eastridge2, Wesley Saintilnord3, Edward Dickinson2, Richard Murphy1, Steven Borst2, Karina Horgan1, Karl Dawson2.
Abstract
Huanglongbing (HLB) is considered the most destructive disease in Citrus production and threatens the future of the industry. Microbial-derived defense elicitors have gained recognition for their role in plant defense priming. This work assessed a 5% (V/V) microbial fermentation application (MFA) and its role in the elicitation of defense responses in HLB-infected Citrus sinensis trees following a foliar application with a pump sprayer. Using a PCR detection method, HLB infection levels were monitored in healthy and infected trees for 20months. Nutrient analysis assessed N, P, K, Ca, Mg, Mn, Zn, Fe, B, and Cu concentrations in the trees. MFA significantly increased Cu concentrations in treated trees and resulted in the stabilization of disease index (DI) in infected trees. Initial real-time qPCR analysis of defense-associated genes showed a significant increase in pathogenesis-related protein 2 (PR2) and phenylalanine ammonia lyase (PAL) gene expression in healthy and HLB-infected trees in response to MFA. Gene expression of PR2 and PAL peaked 6h post-microbial fermentation application during an 8-h sampling period. A transcriptomic assessment using GeneChip microarray of the hour 6 samples revealed differential expression of 565 genes when MFA was applied to healthy trees and 909 genes when applied infected citrus trees when compared to their respective controls. There were 403 uniquely differentially expressed genes in response to MFA following an intersectional analysis of both healthy and infected citrus trees. The transcriptomic analysis revealed that several genes associated with plant development, growth, and defense were upregulated in response to MFA, including multiple PR genes, lignin formation genes, ROS-related genes, hormone synthases, and hormone regulators. This study provides further evidence that MFA may play an important role as a plant elicitor in an integrated pest management strategy in citrus and other agronomically important crops.Entities:
Keywords: Citrus; HLB; citrus greening; fermentation; huanglongbing; microbial elicitors
Year: 2021 PMID: 34917102 PMCID: PMC8669595 DOI: 10.3389/fpls.2021.754391
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Figure 1Huanglongbing (HLB) prevalence and disease progression in Citrus sinensis over the duration of the field investigation. (A) HLB infection as Ct of petiole DNA measurements was made in infected and uninfected citrus tissue for the duration of the trial. (B) Disease index over time. Data represent average disease index rating over time in each experimental group. Letters that are the same within each time point indicate no differences between groups. Error bars represent±SEM.
Disease progression in trees during the period between 8 and 20months of the trial as measured by changes in the severity of infection (DI) in individual trees.
| Condition | Treatment | Number of trees showing increased severity of infection (change in DI>0) | Number of trees showing decreased severity of infection (change in DI<0) | ||
|---|---|---|---|---|---|
| Fraction | Percent | Fraction | Percent | ||
| Unchallenged trees | Control | 1/11 | 9% | 0/11 | 0% |
| MFA | 0/12 | 0% | 2/12 | 17% | |
| Infected trees | Infected | 12/17a | 71% | 0/17a | 0% |
| MFA+Infected | 7/20b | 35% | 5/20b | 25% | |
| All trees | No MFA Treatment | 13/28a | 46% | 0/28a | 0% |
| MFA Treated | 7/32b | 21% | 7/32b | 21% | |
Differences in superscripts (a, b) indicate the distribution of the change in disease severity (DI) differs between the MFA treated and untreated groups of trees (p<0.05).
Leaf tissue nutrient analysis from Citrus sinensis after long-term MFA treatment.
| % | Ppm | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Treatment | N | P | K | Ca | Mg | Mn | Zn | Fe | B | Cu |
| Control | 3.22±0.11a | 0.18±0.01a | 1.98±0.08a | 3.76±0.27a | 0.28±0.01a | 39.80±6.36a | 41.80±5.12a | 88.40±6.23a | 168.00±16.44a | 9.8±0.7a |
| Infected | 2.98±0.14a | 0.16±0.01a | 1.84±0.05a | 3.22±0.17ab | 0.22±0.01b | 38.40±5.10a | 35.40±0.07a | 73.80±7.17a | 185.40±16.26a | 9.4±0.3a |
| MFA | 3.18±0.09a | 0.20±0.01a | 1.82±0.07a | 2.92±0.15ab | 0.29±0.01a | 48.00±14.27a | 44.80±2.42a | 86.00±9.35a | 162.80±36.69a | 32.4±5.4b |
| MFA+Infected | 3.04±0.07a | 0.19±0.01a | 2.00±0.11a | 2.44±0.25b | 0.25±0.01ab | 37.20±9.90a | 40.20±4.82a | 71.00±5.37a | 184.00±15.37a | 26.8±6.69b |
Data presented represent means of each treatment group for each mineral or nutrient tested. Letters that are the same within each column indicate no differences between groups (n=5). Error is represented as±SEM.
Figure 2Impact of microbial fermentation application (MFA) on gene expression levels of defense genes in healthy and infected Citrus sinensis trees. Data represent gene expression of (A) beta-1,3-endoglucanase (PR2) and (B) phenylalanine ammonia lyase (PAL) over 5 time points 0, 2, 4, 6, and 8h after MFA treatment (n=7). Both treatments were normalized to their respective controls. MFA trees were normalized to control trees, and MFA+infected trees were normalized to the infected group. Letters that are the same within each time point indicate no differences between groups (p>0.05). Error bars indicate±SEM.
Figure 3Summary of gene expression data from Citrus sinensis. (A) Number of significantly differentially expressed genes between different combinations of experimental groups. (B) Venn diagram displaying number of intersecting genes between healthy and HLB-infected Citrus sinensis following treatment with MFA. Venn diagram was generated by comparing gene expression sets. Venn diagram displays the common tally of genes that are impacted by the experimental conditions. Numbers represent significantly differentially expressed genes (p<0.05), and percentages represent the percentage of the total tally. (Oliveros, 2007–2015). Venny 2.1.0. https://bioinfogp.cnb.csic.es/tools/venny/. (C–E) Principal component analysis (PCA) plots indicating relationships between differentially expressed genes in MFA-treated samples and control treatments. Oval shapes indicate treatment grouping (control, infected, MFA, MFA+infected). A, C, D, and E graphs were generated by the TAC console.
A sample of the differentially expressed genes in the control vs. infected groups.
| Gene ID | Description | Fold change |
|
|---|---|---|---|
|
| |||
| Cit.10009.1.S1_s_at | Unknown | 11.43 | 0.0281 |
| Cit.15054.1.S1_at | Hypothetical protein | 11.07 | 0.0067 |
| Cit.7276.1.S1_at | Uncharacterized LOC102630205 | 10.49 | 0.0042 |
| Cit.23470.1.S1_s_at | Uncharacterized LOC102625551 | 9.73 | 0.0064 |
| Cit.7727.1.S1_at | Early nodulin-like protein 3-like | 9.56 | 0.0020 |
| Cit.20586.1.S1_at | Unknown | 8 | 0.0383 |
| Cit.30043.1.S1_at | Unnamed protein product homologue ( | 7.68 | 0.0104 |
| Cit.7736.1.S1_at | Unnamed protein homologue ( | 7.68 | 0.0104 |
| Cit.29883.1.S1_a_at | Kinesin-4-like | 6.59 | 0.0097 |
| Cit.681.1.S1_x_at | Unknown | 6.09 | 0.0203 |
|
| |||
| Cit.13366.1.S1_at | Chalcone synthase homologue ( | −5.03 | 0.0297 |
| Cit.5973.1.S1_s_at | Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C-like | −4.67 | 0.0182 |
| Cit.17562.1.S1_at | Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C-like | −3.93 | 0.0205 |
| Cit.31451.1.S1_s_at | ATC protein | −3.34 | 0.0021 |
| Cit.17724.1.S1_s_at | Xyloglucan endotransglucosylase/hydrolase protein 22-like | −2.76 | 0.0009 |
| Cit.13424.1.S1_at | Putative cytochrome P450 protein homologue ( | −2.68 | 0.0026 |
| Cit.9523.1.S1_s_at | Translocator protein homolog | −2.67 | 0.0354 |
| Cit.18045.1.S1_s_at | Ethylene-responsive transcription factor ERF023-like | −2.65 | 0.0011 |
| Cit.30513.1.S1_x_at | Syringolide-induced protein 19-1-5 homologue ( | −2.62 | 6.27E-06 |
| Cit.9421.1.S1_s_at | Probable xyloglucan endotransglucosylase/hydrolase protein 23-like | −2.6 | 5.70E-05 |
A sample of the differentially expressed genes in the control vs. MFA-treated groups.
| Gene ID | Description | Fold change |
|
|---|---|---|---|
|
| |||
| Cit.17838.1.S1_at | Uncharacterized LOC102619854 | 56.59 | 1.52E-05 |
| Cit.3761.1.S1_x_at | Uncharacterized LOC102619665 | 39.39 | 5.42E-07 |
| Cit.1441.1.S1_at | Acetyltransferase-like protein homologue ( | 33.12 | 3.13E-10 |
| Cit.18037.1.S1_at | 1-aminocyclopropane-1-carboxylate synthase 1-like | 29.49 | 4E-11 |
| Cit.2409.1.S1_s_at | laccase-7-like | 22.38 | 1.4E-12 |
| Cit.17291.1.S1_at | O-methyltransferase homologue ( | 22.32 | 6.30E-09 |
| Cit.17178.1.S1_x_at | Unknown | 21.27 | 1.53E-07 |
| Cit.3377.1.S1_at | Blue copper protein-like | 20.96 | 6.6E-10 |
| Cit.29411.1.S1_s_at | BAHD acyltransferase At5g47980-like | 20.23 | 1.56E-10 |
| Cit.7362.1.S1_at | Cytochrome P450 83B1-like | 19.53 | 7.3E-10 |
|
| |||
| Cit.16432.1.S1_at | Hypothetical protein | −3.83 | 0.0002 |
| Cit.9523.1.S1_s_at | Translocator protein homolog | −3.48 | 0.0339 |
| Cit.3534.1.S1_s_at | Uncharacterized LOC102616771 | −3.18 | 0.0153 |
| Cit.21126.1.S1_s_at | Auxin-induced protein 22D-like | −3 | 5E-05 |
| Cit.2093.1.S1_s_at | Expansin-A5-like | −2.66 | 0.0483 |
| Cit.8231.1.S1_s_at | Purple acid phosphatase 8-like | −2.62 | 0.0022 |
| Cit.29521.1.S1_x_at | Regulator of chromosome condensation-like protein homolog ( | −2.6 | 0.0009 |
| Cit.29521.1.S1_at | Regulator of chromosome condensation-like protein homolog ( | −2.55 | 0.0014 |
| Cit.38030.1.S1_at | Protein ECERIFERUM 1-like | −2.51 | 0.0006 |
| Cit.17407.1.S1_at | Auxin-induced protein 22D-like | −2.46 | 6E-05 |
A sample of the differentially expressed genes in the infected vs. MFA+infected groups.
| Gene ID | Description | Fold change |
|
|---|---|---|---|
|
| |||
| Cit.2409.1.S1_s_at | Laccase-7-like | 43.29 | 4.46E-14 |
| Cit.1441.1.S1_at | Unknown | 43.23 | 1.43E-10 |
| Cit.26572.1.S1_at | Uncharacterized LOC102607820 | 37.15 | 2.50E-08 |
| Cit.3761.1.S1_x_at | Uncharacterized LOC102619665 | 32.54 | 3.29E-07 |
| Cit.18037.1.S1_at | 1-aminocyclopropane-1-carboxylate synthase 1-like | 31.54 | 2.58E-11 |
| Cit.29411.1.S1_s_at | BAHD acyltransferase At5g47980-like | 27.46 | 4.49E-11 |
| Cit.26572.1.S1_s_at | Uncharacterized LOC102607820 | 24.17 | 9.71E-09 |
| Cit.17178.1.S1_x_at | Unknown | 22.58 | 1.72E-07 |
| Cit.3377.1.S1_at | Blue copper protein-like | 21.58 | 3.80E-10 |
| Cit.17838.1.S1_at | Uncharacterized LOC102619854 | 21.44 | 9.41E-05 |
|
| |||
| Cit.35493.1.S1_s_at | Uncharacterized LOC102612783 | −11.1 | 0.0364 |
| Cit.21179.1.S1_at | Chalcone synthase 2 homologue ( | −7.53 | 0.0003 |
| Cit.8600.1.S1_x_at | Chalcone synthase 2 homologue ( | −5.22 | 0.0007 |
| Cit.19520.1.S1_s_at | Chalcone synthase 2-like | −4.7 | 0.001 |
| Cit.38030.1.S1_at | Protein ECERIFERUM 1-like | −4.5 | 3.57E-05 |
| Cit.30458.1.S1_s_at | Chalcone synthase 2-like | −3.97 | 0.0016 |
| Cit.19520.1.S1_x_at | Chalcone synthase 2-like | −3.89 | 0.0014 |
| Cit.34812.1.S1_s_at | Glycine-rich cell wall structural protein 1-like | −3.8 | 0.0052 |
| Cit.39287.1.S1_s_at | GDSL esterase/lipase EXL1-like | −3.7 | 0.0037 |
| Cit.27421.1.S1_at | Putative copia-like retrotransposon protein homologue ( | −3.52 | 0.0009 |